Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DGK6R3
|
|||
| Drug Name |
Valiloxybate
|
|||
| Synonyms |
Valiloxibic acid; VALILOXYBATE; 4-((L-Valyl)oxy)butanoic acid; 238401-16-6; Valiloxybate [USAN]; XWL-008; XW10172; 9B8NWP8K91; L-Valine, 3-carboxypropyl ester; XW-10172; starbld0003028; VALILOXYBATE [INN]; UNII-9B8NWP8K91; SCHEMBL3730354; CHEMBL5095201; WHO 11367; AKOS040757642; MS-23099; HY-137429; CS-0138627; 4-[(2S)-2-amino-3-methylbutanoyl]oxybutanoic acid; 4-{[(2S)-2-amino-3-methylbutanoyl]oxy}butanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 2 | [1] | |
| Company |
XWPharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H17NO4
|
|||
| Canonical SMILES |
CC(C)C(C(=O)OCCCC(=O)O)N
|
|||
| InChI |
InChI=1S/C9H17NO4/c1-6(2)8(10)9(13)14-5-3-4-7(11)12/h6,8H,3-5,10H2,1-2H3,(H,11,12)/t8-/m0/s1
|
|||
| InChIKey |
RMGPNQKZEPTAOC-QMMMGPOBSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05056194) A Double-blind, Randomized, Placebo-controlled, Parallel, Study to Assess the Efficacy and Safety of XW10172 MR for the Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.